Hepatic resection and blood transfusion increase morbidity after cytoreductive surgery and HIPEC for colorectal carcinomatosis.
C Soldevila-VerdeguerJuan José Segura-SampedroC Pineño-FloresP Sanchís-CortésX González-ArgenteR Morales-SorianoPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)
CRS-HIPEC is a feasible treatment for colorectal PM with an acceptable morbi-mortality rate in experienced centers. In our study, digestive anastomosis, perioperative blood transfusion, hepatic resection, and lymph-node infiltration were associated with higher morbidity rates.
Keyphrases
- lymph node
- minimally invasive
- particulate matter
- cardiovascular events
- air pollution
- cardiac surgery
- neoadjuvant chemotherapy
- heavy metals
- risk factors
- type diabetes
- cardiovascular disease
- coronary artery disease
- radiation therapy
- risk assessment
- polycyclic aromatic hydrocarbons
- surgical site infection
- early stage
- acute coronary syndrome
- atrial fibrillation
- rectal cancer